Early MRI and outcomes of untreated patients with mild or improving ischemic stroke

Neurology

Volumn 67, Issue 6, 2006, Pages 980-984

  Rajajee, V ^a,b   Kidwell, C ^a   Starkman, S ^a   Ovbiagele, B ^a   Alger, J R ^a   Villablanca, P ^a   Vinuela, F ^a   Duckwiler, G ^a   Jahan, R ^a   Fredieu, A ^a   Suzuki, S ^a   Saver, J L ^a  

^a UCLA MEDICAL CENTER   (United States)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; DISEASE EXACERBATION; EARLY DIAGNOSIS; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; POOR GENERAL CONDITION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RANKIN SCALE; RISK ASSESSMENT; SCORING SYSTEM; STROKE; STROKE PATIENT; THERAPY DELAY;

CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVALS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL RECORDS; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; REPERFUSION; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR DISEASES;

EID: 33749037692     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000237520.88777.71     Document Type: Article

References (13)

1. Adams HP Jr, Adams RJ, Brott T, et al. Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
2. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism JAMA 1999;282:2003-2011.
3. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-1438. Epub 2005 Jun 16.
4. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001;56:1015-1020.
5. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. Cleveland Clinic Health System Stroke Quality Improvement Team. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004;61:346-350.
6. Grotta JC, Welch KM, Fagan SC, et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001;32:661-668.
7. Kleindorfer D, Kissela B, Schneider A, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 2004;35:e27-e29.
8. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 2005;36:2497-2499. Epub 2005 Oct 6.
9. Biller J, Love BB, Marsh EEIII, et al. Spontaneous improvement after acute ischemic stroke. A pilot study. Stroke 1990;21:1008-1012.
10. Alexandrov AV, Felberg RA, Demchuk AM, et al. Deterioration following spontaneous improvement: sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke 2000;31:915-919.
11. Saver JL, Starkman S. State of the art medical management of acute ischemic stroke. J Stroke Cerebrovasc Dis 1997;6:189-194.
12. Rajajee V, Kidwell C, Starkman S, et al. Accuracy of clinical diagnosis of lacunar infarct within 6 hours of onset compared to early MRI-DWI and MRA. Stroke 2004;35:262. Abstract.
13. National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience. Ann Emerg Med 2005;46:243-252.